Cubist Pharmaceuticals (Lexington, ...

Cubist Pharmaceuticals (Lexington, MA) has announced preliminary issues for the first of pair pivotal Phase 3 trials of Cidecin (daptomycin for injection) in the treatment of community-acquired pneumonia requiting hospitalization (the CAP1 Study) In the overall international application of mind which included populations in Eastern Europe and southerly Africa, the primary endpoint of demonstrating non-inferiority to an active comparator agent, Rocephin (ceftriaxone sodium), was not achieved. However, the endpoint was achieved in the intent-to-treat and clinically evaluable cohorts representing the

Play Fun Flash Games , Hoodia Gordonii , Bowel Iritable Syndrome , One.com Surftown Jamfor Webhotel , Helsebutikken Xango Mangosteenjuice